Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI
Chao Ma1,2, Jun Wang1,2, Junying Zhang1,2
1State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, No. 19 Xinjiekouwai Street, Beijing, 100875, China.
The apolipoprotein E (APOE) ε4 allele and mild cognitive impairment (MCI) interact to worsen cognitive function and brain connectivity. This finding may help identify early Alzheimer's disease (AD) biomarkers.
Area of Science:
- Neuroscience
- Genetics
- Gerontology
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder with significant genetic and age-related risk factors.
- The apolipoprotein E (APOE) ε4 allele is a major genetic risk factor for AD.
- Mild cognitive impairment (MCI) is an intermediate stage between normal aging and AD, also associated with increased AD risk.
Purpose of the Study:
- To investigate the interaction between the APOE ε4 allele and MCI in a Chinese Han population.
- To identify potential synergistic effects that could serve as biomarkers for early AD detection and intervention.
Main Methods:
- Neuropsychological tests and APOE genotyping were performed on 885 Han Chinese subjects (≥55 years).
- Structural and diffusion tensor MRI scans were acquired for 110 participants.
- Subjects were categorized into four groups: ε4+ MCI, ε4+ normal cognition (NC), ε4- MCI, and ε4- NC.
Main Results:
- Significant interactions between APOE ε4 and MCI were observed in general cognitive function (p=0.001) and white matter network connectivity (p<0.05).
- The combination of APOE ε4 positivity and MCI was associated with reduced Mini-Mental Status Examination (MMSE) scores.
- This combination also showed decreased global white matter network connectivity and right hippocampus (rHIP) nodal efficiency.
Conclusions:
- The co-occurrence of APOE ε4 and MCI exacerbates cognitive decline and disrupts brain network integrity.
- These interacting factors represent promising targets for developing sensitive biomarkers for early AD diagnosis.
- Findings support the utility of combined genetic and cognitive assessments in clinical trials for early-stage AD.
More Related Videos
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
